Loading clinical trials...
Loading clinical trials...
Clinical Trial for the Safety and Efficacy of NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
Conditions
Interventions
NKG2D CAR T-cells
Locations
1
China
The First Affiliated Hospital，College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Start Date
January 15, 2021
Primary Completion Date
January 15, 2024
Completion Date
January 15, 2027
Last Updated
December 8, 2020
NCT06285890
NCT06220162
NCT04065399
NCT06994676
NCT04628026
NCT06484062
Lead Sponsor
Zhejiang University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions